Sumatriptan succinate
What is Sumatriptan succinate?
Sumatriptan succinate (CAS 103628-48-4) is the succinate salt form of sumatriptan, a selective serotonin receptor agonist; the active pharmaceutical ingredient in acute migraine and cluster headache treatments.
Where is Sumatriptan succinate used?
- Prescription migraine therapies: API
- Tablets, nasal sprays and subcutaneous injections for rapid symptom relief
- Solid oral dosage forms requiring precise particle size
- Reformulation projects targeting modified-release or needle-free delivery platforms
- Generic drug manufacturers develop bioequivalent products to reference-listed branded formulations.
Good to know: Polymorphic consistency directly affects bioavailability and dissolution performance.
Commercial specifications
- Pharmaceutical-grade specifications conforming to USP and BP monographs
- Documentation: CoA, DMF references, ICH-compliant impurity profiles
- Packaging from research-scale grams to commercial kilogram lots
Other Names (Synonyms)
sumatriptan hydrogen succinate|3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide succinate|Sumavel DosePro|Alsuma|Onzetra Xsail|Imitrex Statdose|GR 43175C|Zembrace SymTouch